Abstract:Objective:To explore the effect of the acute treatment outcome on the trajectory of residual symptoms for major depressive disorder (MDD).Method:This is a multicenter, prospective, non-intervention study. The MDD patients who self-reported an improvement after received an 8-12 weeks antidepressant treatment were included. Social-demographic and clinical characteristics were collected at the baseline. Brief 16-item Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR 16), Generalized Anxiety Disorder Scale (GAD-7), Arizona Sexual Experience Scale experience (ASEX), Digital Span Test (DST) and Digit Symbol Substitution Test (DSST) were used to assess the symptoms. Patients were followed up at month 1, 3 and 6. Mix effect model and generalized estimating equation were used to analysis changes over visits of symptoms within or between groups. Result:Totally, 428 eligible patients were included in this study. At baseline, 179 patients achieved remission (41.8%,179/428) and 249 achieved partial remission (58.2%,249/428). There were no significant differences in demographics, clinical characteristics and treatment between the two groups. The proportion of increased appetite, weight gain, suicidal ideation, and restlessness in the remission group did not change significantly over time ( Z=-1.62-1.34, all P>0.003), meanwhile, the proportion of hypersomnia, increased appetite, and weight gain in the partial remission group did not change significantly over the course of the assessments ( Z=-2.43- -1.26, all P>0.003). The proportion of other residual symptoms changed significantly from baseline to 6-month follow-up in both groups ( Z=-10.77- -2.46, all P<0.003), nevertheless, there was no significant difference between the two groups ( Z=0.37-3.26, all P>0.003). The total score of GAD-7 of the two groups were significantly different at each assessment timepoint (χ 2=24.68-113.80, P<0.01), and the improvement of anxiety in the remission group was better than that in the partial remission group ( F=8.39, P<0.01). There were no significant differences in the total ASEX scores between the two groups at each visit ( F=-1.93- -0.68, all P>0.05), and there were no significant difference within the group ( F=0.01-0.17, P>0.05). There was no significant difference in the total scores of DST and DSST between the two groups at baseline ( F=-1.23, -1.14, all P>0.05), and also no significant differences were found during all follow-up visits after control for score at baseline ( F=-1.14- -0.91, all P>0.05). Conclusions:The treatment outcome of the acute phase has an impact on the residual symptoms of MDD. Remission has a positive effect on the improvement of anxiety, but has no significant effect on the improvement of sexual dysfunction and cognitive function.

One year outcome of patients with comorbid depression and anxiety disorders

Multi-center study of the clinical features in depression comorbidity with anxiety disorders

Suicide Risk in Major Affective Disorder: Results from a National Survey in China.

[Study on Anxiety and Depressive Disorder of Inpatients in General Hospital].

Effects of treatment outcome in acute phase of depression on residual symptoms in a 6-month follow-up: a national, multicenter study

Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder

Associations Between Cognitive Symptoms and Functional Outcomes in Chinese Patients with Depression in a 6-Month Non-Interventional, Prospective Study

Clinical study of major depression comorbid with anxiety

Comorbid Mental Disorders and 6-Month Symptomatic and Functioning Outcomes in Chinese University Students at Clinical High Risk for Psychosis

Depressive symptoms in first-episode schizophrenia:A 9-year follow-up study

Concordance between subjective experience and clinician-rated for depression severity in elderly patients with depressive disorder: 1-year follow-up study

The Prevalence and Clinical Correlates of Anxiety in Chinese Patients with First-Episode and Drug-Naïve Major Depressive Disorder at Different Ages of Onset

Prevalence and clinical profile of comorbid anxiety in young adult patients with first-episode and drug-naive major depressive disorder

Comparing the Effects of Depression, Anxiety, and Comorbidity on Quality-of-life, Adverse Outcomes, and Medical Expenditure in Chinese Patients with Acute Coronary Syndrome.

The Efficacy of Cognitive-Behavioral Education and Self-Management on the Recurrent or Deterioration of Depression

Help-seeking During 1-Year Follow-Up in Chinese Patients Diagnosed with Type 2 Diabetes Mellitus Comorbid Major Depressive Disorder

Antipsychotic Alone Venus Combined with Psychosocial Intervention on One-Year Outcome in Non-Chronic Schizophrenia

Restoration of psychosocial functioning in remitted major depressive disorder patients: A 1-year longitudinal study

Characteristics and related factors of comorbidity among patients with depression disorder

Comorbidity of Anxiety and Depression in Geriatric Patients

Research on Cognitive Function in Anxious Depression Patients in China